These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9852715)

  • 1. [Effect of matrix metalloproteinase inhibitor on experimental pseudomonal corneal ulceration].
    Kosaku K; Maeda N; Yokoyama T; Inoue T; Yoshida Y; Hosokawa T; Sawa M
    Nippon Ganka Gakkai Zasshi; 1998 Nov; 102(11):717-23. PubMed ID: 9852715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of matrix metalloproteinase inhibitor on pseudomonal proteinases].
    Kosaku K; Maeda N; Yokoyama T; Inoue T; Yoshida Y; Hosokawa T; Sawa M
    Nippon Ganka Gakkai Zasshi; 1998 Feb; 102(2):83-7. PubMed ID: 9513352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a synthetic metalloproteinase inhibitor on corneal ulceration in alkali burns and pseudomonas keratitis.
    Burns FR; Gray RD; Wells JT; Paterson CA
    Matrix Suppl; 1992; 1():317-8. PubMed ID: 1480049
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
    Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
    Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
    Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of peptide-based matrix metalloproteinase inhibitors in corneal ulceration.
    Gray RD; Paterson CA
    Ann N Y Acad Sci; 1994 Sep; 732():206-16. PubMed ID: 7978792
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn.
    Wentworth JS; Paterson CA; Gray RD
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2174-9. PubMed ID: 1607227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro.
    Miyajima S; Akaike T; Matsumoto K; Okamoto T; Yoshitake J; Hayashida K; Negi A; Maeda H
    Microb Pathog; 2001 Dec; 31(6):271-81. PubMed ID: 11747375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinase-13 as a Target for Suppressing Corneal Ulceration Caused by Pseudomonas aeruginosa Infection.
    Gao N; Kumar A; Yu FS
    J Infect Dis; 2015 Jul; 212(1):116-27. PubMed ID: 25589337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.
    Wang L; Pan Q; Xue Q; Cui J; Qi C
    Am J Vet Res; 2008 Oct; 69(10):1341-5. PubMed ID: 18828693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide.
    Burns FR; Gray RD; Paterson CA
    Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):107-14. PubMed ID: 2153643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
    Levy JH; Katz HR
    Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinases of the cornea and preocular tear film.
    Ollivier FJ; Gilger BC; Barrie KP; Kallberg ME; Plummer CE; O'Reilly S; Gelatt KN; Brooks DE
    Vet Ophthalmol; 2007; 10(4):199-206. PubMed ID: 17565550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiproteolytic agents on corneal epithelial viability and matrix metalloproteinase-2 and metalloproteinase-9 activity in alkali-burned corneas of rats.
    Piso DY; Ribeiro AP; Silva ML; Guimarães PJ; Morales A; Martins BC; Padua IM; Renzo R; Andrade AL; Uscátegui RR; Laus JL
    Vet Ophthalmol; 2014 Jan; 17(1):23-31. PubMed ID: 23433350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin treatment of pseudomonal corneal infection.
    Stuart JC; Turgeon PT; Kowalski RP
    Cornea; 1991 Jan; 10(1):63-6. PubMed ID: 1708325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.
    Tao Y; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):345-54. PubMed ID: 7843905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases.
    Schultz GS; Strelow S; Stern GA; Chegini N; Grant MB; Galardy RE; Grobelny D; Rowsey JJ; Stonecipher K; Parmley V
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3325-31. PubMed ID: 1385350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.